An ethical framework for the creation, governance and evaluation of accelerated access programs

Regulators and insurers around the world face the challenge of providing timely access to safe and effective medicines that both consumers and the community can afford. Current regulatory and reimbursement systems have been established in order to protect patients from harmful and ineffective treatments and ensure the sustainability of health systems. However, in recent years there has been increasing claims —particularly by industry and patient advocates—that these systems act as a barrier to patients receiving timely access to new medicines.

Source: Health Policy - July 20, 2018 Category: Health Management Authors: Jessica Pace, Narcyz Ghinea, Ian Kerridge, Wendy Lipworth Source Type: research